Aglaia launches Oncology Fund II

Aglaia is aiming to raise $80-100m for Oncology Fund II.

The fund is the third under Aglaia's management. The firm has also raised Aglaia Oncology Fund and Aglaia Oncology Seed Fund, the latter of which launched in 2005 and raised €8m.

Investors
The fund has already secured $65m in commitments from investors. Backers include several high-net-worth families and institutional investors, the latter of which are new investors for Aglaia.

European Investment Fund (EIF) and the European Investment Bank-backed risk capital resources mandate have jointly committed €20m to the fund.

Oncology Fund II also received a commitment from the Dutch Venture Initiative (DVI), a €150m fund-of-funds that backs venture capital firms investing in the Netherlands technology economy. DVI was established by EIF and PPM Oost, which contributed €50m and €100m respectively to the fund-of-funds, and is supported by the Dutch Ministry of Economic Affairs.

Investments
The fund intends to invest in 10-15 start-ups in the life sciences sector with a strict focus on businesses developing anti-cancer therapies.

People
Mark Krul is a partner at Aglaia.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Venture
• Healthcare
• Netherlands